Gilde Healthcare’s private equity fund today announced the acquisition of MEG Medical Equipment GmbH (“MEG”), a provider of high-quality medical aids for treatment and prevention of decubitus and other skin damages resulting from extended immobility, from HQIB. In partnership with Gilde Healthcare, MEG will accelerate its growth – both organically and through acquisitions.
MEG is a combination of two companies: Funke Medical GmbH (Germany) and Deron B.V. (Netherlands). Both companies are leading providers of high-quality and specialized medical equipment for the prevention and therapy of decubitus. Their complementary product portfolio includes medical mattresses, beds and related products. MEG sets new standards in innovation and environmental responsibility within the medical aids sector via a continuously expanding portfolio of sustainable mattresses and smart care solutions.
MEG is well positioned to enter new market segments and expand into adjacent application areas, with active support from Gilde Healthcare. Through further acquisitions, MEG intends accelerate its international expansion.
Dr. Ramona Koenig, CEO of MEG commented “MEG was established in 2021 by HQIB with the vision of building the nucleus for a leading medical equipment group. We are proud of the progress that we have made to date with the highly complementary combination of Funke Medical and Deron together with HQIB. We are thrilled to form this partnership with Gilde Healthcare to continue our growth journey in the coming years. With Gilde Healthcare’s deep sector expertise as well as additional financial resources we are excited to further accelerate our international growth.”
Robert Stein, Partner at Gilde Healthcare commented “We are excited to partner with MEG and look forward to supporting the team on the ambitious growth path. We are impressed by MEGs strong market position, high-quality medical products, as well as the commitment to delivering technology-enabled and sustainable solutions. This aligns perfectly with our strategy to invest in companies that drive positive change in healthcare. Together, we will focus on building out the strong market position of MEG. With ongoing consolidation in the market, we see an opportunity to accelerate international growth of the group.”
“We are proud to have entrepreneurially supported MEG for the past years and are delighted to have now, following the successful growth phase and succession of Andreas Funke, found a suitable new owner for the Group in Gilde Healthcare, who supports the new management’s growth strategy. We would like to thank the Funke family, the Grimberg family and Helmut Wessels as founders/ co-shareholders as well as Ramona Koenig and Fernando Varela as top management for the excellent and successful collaboration and we wish MEG and Gilde Healthcare continued success and all the best for the future,’ says Gregor Harald May, Managing Partner of HQIB.
“MEG has been a successful case study of HQIB’s entrepreneurial approach. Thanks to our flexible investment approach as an industrial holding, we have been able to build a platform which we believe will continue to be successful under the new ownership of Gilde Healthcare” adds Florian Kunkel, Director at HQIB.
About MEG Medical Equipment GmbH
MEG combines the two companies Funke Medical and Deron, both providers of high quality medical aids for the prevention and treatment of decubitus in outpatient and homecare settings. Production takes place at two locations in Raesfeld, in North Rhine-Westphalia, Germany. MEG serves an international customer base in Europe and abroad. MEG distinguishes itself due to the high quality product and delivery quality as well as its advanced offering in smart and sustainable solutions. For more information, visit the company’s website at www.funke-medical.de and www.deron.nl
About Gilde Healthcare
Gilde Healthcare is a thematic investment firm managing over €2.6 billion across two fund strategies in healthcare: Private Equity and Venture&Growth. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in digital health, medical technologies (MedTech) and therapeutics, based in Europe and North America. For more information, visit the company’s website at www.gildehealthcare.com.
About Harald Quandt Industriebeteiligungen
Harald Quandt Industriebeteiligungen GmbH is an investment initiative of the Harald Quandt family and a group of selected (industrial) families and partners. HQIB acquires and develops small- and medium-sized companies that are positioned in established, future-orientated and technically sophisticated sectors with attractive growth potential. As an industrial holding company, HQIB pursues a flexible investment strategy and is not subject to any maturity restrictions or fixed holding periods. Further information can be found at www.hq-ib.com.
